Concepedia

Author

Avtandil Tataradze

Astellas Pharma (United States)

Also Known As

A Tataradze, A. Tataradze, Avtandil Tataradze

17

Publications

320

Citations

6

H-Index

0

Concepts

All Affiliations

Astellas Pharma (United States)National Cancer Center of GeorgiaAstellas Pharma (Netherlands)
AT

About

Avtandil Tataradze is an author at Astellas Pharma (United States).

Avtandil Tataradze

×

3

Publications

285

Citations

3

H-Index

YearCitations

Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)

Jonathan Barratt, Branislav Andrić, Avtandil Tataradze,

Nephrology Dialysis Transplantation

2021

136

Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)

Evgeny Shutov, Władysław Sułowicz, Ciro Esposito,

Nephrology Dialysis Transplantation

2021

112

Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA

Paolo Cravedi, Sanjib Kumar Sharma, Rodolfo Flores Bravo,

BMJ Open

2012

37

Page 1